Characteristics of studies of patients of ovarian cancer with low BRCA1 mRNA expression or BRCA1 promoter methylation.

Histology: pathological histology of ovarian cancer, all = almost all of the epithelial ovarian cancer types, including serous, mucinous, clear cell cancer, etc.
Methods of methylation detecting: methods of methylation detecting, MSP = methylation-specific polymerase chain reaction (PCR) analysis, MSRE = methylation-sensitive restriction enzyme digestion.
Treatment: chemotherapy used, 2 = Platinum-based chemotherapy.